Biotech buybacks—good or bad?

被引：0

|

作者：

Tom Jacobs

机构：

来源：

Nature Biotechnology | 2006年 / 24卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：1207 / 1207

相关论文

共 50 条

[31] GOOD TO BE BAD?
Bloomfield, Paul
THINK-PHILOSOPHY FOR EVERYONE, 2015, 14 (40): : 51 - 55
[32] The good and the bad
Sidney Toby
Nature, 2001, 410 : 523 - 523
[33] The Bad is Good
Spitzer, M.
NERVENHEILKUNDE, 2011, 30 (06) : 437 - 442
[34] THE GOOD OR THE BAD
WILLMORE, I
NEW STATESMAN & SOCIETY, 1992, 5 (199): : 29 - 29
[35] THE GOOD AND THE BAD
Davies, Arthur Ernest
INTERNATIONAL JOURNAL OF ETHICS, 1907, 17 (02): : 147 - 163
[36] Good diagnosis for biotech merger
不详
CHEMISTRY & INDUSTRY, 1999, (03) : 83 - 83
[37] Biotech in Good Shape for 2010
Burrill, G. Steven
BIOPHARM INTERNATIONAL, 2010, 23 (01) : 26 - 27
[38] Inequality in the Distribution of a Good is a Bad, and Inequality in the Distribution of a Bad is a Good
Jasso, Guillermina
EUROPEAN SOCIOLOGICAL REVIEW, 2017, 33 (04) : 604 - 614
[39] GOOD DUGONG, BAD DUGONG - BAD TURTLE, GOOD TURTLE
NIETSCHMANN, B
NIETSCHMANN, J
NATURAL HISTORY, 1981, 90 (05) : 54 - &
[40] Lidtumoren – the Good, the Bad, the UglyLid tumors—The Good, the Bad, the Ugly
Vinodh Kakkassery
Die Ophthalmologie, 2023, 120 (3) : 238 - 239

← 1 2 3 4 5 →